Why this grouping
MONDO alignment & provenance
The grouping concept corresponds to the MONDO Robinow syndrome class. exactMatch records the intended conceptual alignment; the FZD2-related form has no MONDO class of its own and is therefore a curation gap rather than evidence that the mapping is only a close match.
Membership criteria
- AND
- OR
Caused by variants in one of the established WNT/PCP pathway genes.
- HAS GENE
WNT5A hgnc:12784
The non-canonical WNT ligand.
- HAS GENE
ROR2 hgnc:10257
The WNT5A co-receptor.
- HAS GENE
DVL1 hgnc:3084
Cytoplasmic transducer.
- HAS GENE
DVL3 hgnc:3087
Cytoplasmic transducer, paralog of DVL1.
- HAS GENE
NXN hgnc:18008
Redox regulator of Dishevelled.
- HAS GENE
WNT5A hgnc:12784
- HAS PHENOTYPE
Mesomelia HP:0003027
Mesomelic limb shortening, the skeletal component of the defining triad.
- OR
Caused by variants in one of the established WNT/PCP pathway genes.
Coverage and gaps
Exact MONDO scope: MONDO:0019978 · Robinow syndrome Completeness is counted over rows inside this exact MONDO scope that are listed in this grouping.
| Status | DisMech entry | MONDO concept | In DisMech | Has MONDO ID | In grouping MONDO | Member state | Conditions satisfied | C1.1 The non-canonical WNT ligand. hgnc:12784 | C1.2 The WNT5A co-receptor. hgnc:10257 | C1.3 Cytoplasmic transducer. hgnc:3084 | C1.4 Cytoplasmic transducer, paralog of DVL1. hgnc:3087 | C1.5 Redox regulator of Dishevelled. hgnc:18008 | C1.6 Mesomelic limb shortening, the skeletal component of the defining triad. HP:0003027 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| listed in scope |
Autosomal Dominant Robinow Syndrome 1
DISEASE
Differentiating mechanismHeterozygous missense alleles substituting highly conserved cysteines in the WNT5A ligand. The alleles are hypomorphic rather than null in functional assays, which is consistent with the milder dominant phenotype relative to complete receptor loss. This is the only form in which the lesion is in the ligand itself.
WNT5A hgnc:12784
|
autosomal dominant Robinow syndrome 1
MONDO:0024455
|
yes | yes | yes | listed | satisfied | SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | SATISFIED |
| listed in scope |
Autosomal Dominant Robinow Syndrome 2
DISEASE
Differentiating mechanismHeterozygous frameshifts confined to the penultimate exon of DVL1, escaping nonsense-mediated decay and producing an altered transducer with a novel -1 reading-frame C-terminus. Uniquely among the members, this form carries the osteosclerotic variant of the syndrome: normal stature, persistent macrocephaly, increased cranial bone mineral density and hearing loss.
DVL1 hgnc:3084
|
autosomal dominant Robinow syndrome 2
MONDO:0014591
|
yes | yes | yes | listed | satisfied | NOT SATISFIED | NOT SATISFIED | SATISFIED | NOT SATISFIED | NOT SATISFIED | SATISFIED |
| listed in scope |
Autosomal Dominant Robinow Syndrome 3
DISEASE
Differentiating mechanismHeterozygous de novo splice-acceptor variants and single-base deletions in DVL3 that all converge on a -1 frameshift of the last exon — the same allele architecture as DVL1, in the paralog. Distinguished from DRS2 by gene and by the absence of the osteosclerotic phenotype.
DVL3 hgnc:3087
|
autosomal dominant Robinow syndrome 3
MONDO:0014819
|
yes | yes | yes | listed | satisfied | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | SATISFIED | NOT SATISFIED | SATISFIED |
| listed in scope |
Autosomal Recessive Robinow Syndrome
DISEASE
Differentiating mechanismBiallelic loss-of-function alleles in the WNT5A co-receptor ROR2, reaching absence of the receptor either through nonsense-mediated decay of truncating transcripts or endoplasmic-reticulum retention of missense protein. The severe end of the spectrum, and the only form with vertebral segmentation defects and rib fusions — the features that gave it the original COVESDEM name.
ROR2 hgnc:10257
|
autosomal recessive Robinow syndrome
MONDO:0009999
|
yes | yes | yes | listed | satisfied | NOT SATISFIED | SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | SATISFIED |
| listed in scope |
Robinow Syndrome, Autosomal Recessive 2
DISEASE
Differentiating mechanismBiallelic variants in nucleoredoxin, a redox regulator of Dishevelled. Recessive like the ROR2 form, but phenotypically clustering with the dominant DVL-related forms — the observation that severity in this grouping tracks position in the cascade rather than allele dosage.
NXN hgnc:18008
|
robinow syndrome, autosomal recessive 2
MONDO:0032800
|
yes | yes | yes | listed | satisfied | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | SATISFIED | SATISFIED |
| MONDO gap | No DisMech entry |
autosomal dominant Robinow syndrome
MONDO:0008389
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
Source
View YAML on GitHubRaw YAML
name: Robinow Syndrome
display_name: Robinow syndrome (WNT/PCP pathway forms)
creation_date: "2026-08-27T00:00:00Z"
description: >-
Robinow syndrome is a genetically heterogeneous skeletal dysplasia defined by
a triad of mesomelic limb shortening, genital hypoplasia and a distinctive
"fetal face" — macrocephaly, a broad prominent forehead, ocular hypertelorism,
a short upturned nose and midface retrusion.
Every established causal gene encodes a component of one signalling module:
the beta-catenin-independent WNT/planar cell polarity pathway. WNT5A is the
ligand, ROR2 and FZD2 the co-receptors, DVL1 and DVL3 the cytoplasmic
transducers, and NXN a redox regulator of Dishevelled. The syndrome therefore
behaves as a pathway disease: genotypes that look unrelated produce one
recognizable clinical entity.
Severity tracks position in the cascade more closely than allele dosage.
Receptor-level loss (biallelic ROR2) is the severe end, adding vertebral
segmentation defects and rib fusions that no other form produces.
Transducer-level lesions are milder — and biallelic NXN disease, despite being
recessive, clusters phenotypically with the heterozygous DVL forms rather than
with ROR2 disease.
grouping_basis:
- SHARED_PATHWAY
- SHARED_MECHANISM
grouping_rationale: >-
Grouped on a shared final-common-pathway mechanism: every member is caused by
loss or alteration of a component of the WNT/planar cell polarity cascade, and
the published framing is explicitly convergent — "six genes that converge on
the WNT/planar cell polarity (PCP) signaling pathway" (PMID:35047859).
The members are deliberately kept as separate Disease entries rather than
merged into one. They differ in the causal gene, in inheritance mode
(ROR2 and NXN recessive, the rest dominant), in the direction and nature of
the molecular lesion (a hypomorphic ligand in WNT5A disease, absent receptor
in ROR2 disease, an NMD-escaping altered transducer in the DVL forms), and in
clinically separable features — vertebral segmentation defects and rib fusions
confined to the ROR2 form, osteosclerosis with preserved stature confined to
the DVL1 form. The ISDS Nosology lists them as six separate rows and MONDO
gives most of them their own class.
This is a grouping over distinct entities, not a lumping of them into one
disease. Whether a single lumped Robinow entry would serve readers better
remains an open question; the split is the current convention and the
grouping is what makes the union visible without pre-empting that decision.
mappings:
mondo_mappings:
- term:
id: MONDO:0019978
label: Robinow syndrome
mapping_predicate: skos:exactMatch
mapping_source: MONDO
mapping_justification: >-
The grouping concept corresponds to the MONDO Robinow syndrome class.
exactMatch records the intended conceptual alignment; the FZD2-related
form has no MONDO class of its own and is therefore a curation gap rather
than evidence that the mapping is only a close match.
membership_criteria:
- description: >-
A disorder belongs to the Robinow syndrome grouping if it is caused by
variants in a gene encoding a component of the WNT/planar cell polarity
signalling cascade AND presents with mesomelic limb shortening.
criteria_semantics: NECESSARY
logic:
operator: AND
operands:
- operator: OR
description: >-
Caused by variants in one of the established WNT/PCP pathway genes.
operands:
- criterion_predicate: HAS_GENE
gene:
preferred_term: WNT5A
term:
id: hgnc:12784
label: WNT5A
description: The non-canonical WNT ligand.
- criterion_predicate: HAS_GENE
gene:
preferred_term: ROR2
term:
id: hgnc:10257
label: ROR2
description: The WNT5A co-receptor.
- criterion_predicate: HAS_GENE
gene:
preferred_term: DVL1
term:
id: hgnc:3084
label: DVL1
description: Cytoplasmic transducer.
- criterion_predicate: HAS_GENE
gene:
preferred_term: DVL3
term:
id: hgnc:3087
label: DVL3
description: Cytoplasmic transducer, paralog of DVL1.
- criterion_predicate: HAS_GENE
gene:
preferred_term: NXN
term:
id: hgnc:18008
label: NXN
description: Redox regulator of Dishevelled.
- criterion_predicate: HAS_PHENOTYPE
description: >-
Mesomelic limb shortening, the skeletal component of the defining triad.
phenotype_term:
preferred_term: Mesomelia
term:
id: HP:0003027
label: Mesomelia
members:
- member: Autosomal Dominant Robinow Syndrome 1
member_type: DISEASE
display_name: DRS1 (WNT5A-related)
differentiating_mechanisms:
- description: >-
Heterozygous missense alleles substituting highly conserved cysteines in
the WNT5A ligand. The alleles are hypomorphic rather than null in
functional assays, which is consistent with the milder dominant phenotype
relative to complete receptor loss. This is the only form in which the
lesion is in the ligand itself.
gene:
preferred_term: WNT5A
term:
id: hgnc:12784
label: WNT5A
- member: Autosomal Dominant Robinow Syndrome 2
member_type: DISEASE
display_name: DRS2 (DVL1-related)
differentiating_mechanisms:
- description: >-
Heterozygous frameshifts confined to the penultimate exon of DVL1,
escaping nonsense-mediated decay and producing an altered transducer with
a novel -1 reading-frame C-terminus. Uniquely among the members, this form
carries the osteosclerotic variant of the syndrome: normal stature,
persistent macrocephaly, increased cranial bone mineral density and
hearing loss.
gene:
preferred_term: DVL1
term:
id: hgnc:3084
label: DVL1
- member: Autosomal Dominant Robinow Syndrome 3
member_type: DISEASE
display_name: DRS3 (DVL3-related)
differentiating_mechanisms:
- description: >-
Heterozygous de novo splice-acceptor variants and single-base deletions in
DVL3 that all converge on a -1 frameshift of the last exon — the same
allele architecture as DVL1, in the paralog. Distinguished from DRS2 by
gene and by the absence of the osteosclerotic phenotype.
gene:
preferred_term: DVL3
term:
id: hgnc:3087
label: DVL3
- member: Autosomal Recessive Robinow Syndrome
member_type: DISEASE
display_name: RRS (ROR2-related)
differentiating_mechanisms:
- description: >-
Biallelic loss-of-function alleles in the WNT5A co-receptor ROR2, reaching
absence of the receptor either through nonsense-mediated decay of
truncating transcripts or endoplasmic-reticulum retention of missense
protein. The severe end of the spectrum, and the only form with vertebral
segmentation defects and rib fusions — the features that gave it the
original COVESDEM name.
gene:
preferred_term: ROR2
term:
id: hgnc:10257
label: ROR2
- member: Robinow Syndrome, Autosomal Recessive 2
member_type: DISEASE
display_name: RRS2 (NXN-related)
differentiating_mechanisms:
- description: >-
Biallelic variants in nucleoredoxin, a redox regulator of Dishevelled.
Recessive like the ROR2 form, but phenotypically clustering with the
dominant DVL-related forms — the observation that severity in this
grouping tracks position in the cascade rather than allele dosage.
gene:
preferred_term: NXN
term:
id: hgnc:18008
label: NXN
notes: >-
Members not yet curated as their own entries.
FZD2-related Robinow syndrome is listed by the ISDS Nosology as row
NOS 15-0080 and was established alongside NXN in the WNT5A-interactome screen
(PMID:29276006), but MONDO has no class for it and the nosology table gives it
no MIM number, so there is nothing to key a dismech entry on. FZD2 also causes
autosomal dominant omodysplasia, which IS curated
(``kb/disorders/Omodysplasia.yaml``, the OMOD2 subtype), and the two
presentations overlap clinically — whether they are one continuum is an open
question recorded in that entry.
DVL2 has a single reported Robinow-associated variant (PMID:35047859) and
GPC4 and RAC3 are single-family candidates (PMID:29276006). None is an
established subtype in MONDO or the ISDS Nosology, so none is a member here.
They are described in the member entries' genetic sections with
``relationship_type: UNKNOWN``.
Brachydactyly type B is allelic at ROR2 but is deliberately NOT a member: the
alleles sit downstream of the Robinow positions and act by gain of function or
dominant negative rather than loss of function, so it fails the mechanism
premise of this grouping rather than merely differing in severity.
references:
- reference: PMID:35047859
title: "Novel pathogenic variants and quantitative phenotypic analyses of Robinow syndrome: WNT signaling perturbation and phenotypic variability."
- reference: PMID:29276006
title: "WNT Signaling Perturbations Underlie the Genetic Heterogeneity of Robinow Syndrome."